Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM5 | P08912 | 1/20 | 0.37 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.37 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.36 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.36 |
| ▸ | SLC6A1 | P30531 | 4/20 | 0.34 |
| ▸ | SLC6A11 | P48066 | 3/20 | 0.34 |
| ▸ | SLC6A13 | Q9NSD5 | 3/20 | 0.34 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.34 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.34 |
| ▸ | SLC6A12 | P48065 | 2/20 | 0.34 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.34 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.34 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.34 |
| ▸ | HTR2C | P28335 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | HTR6 | P50406 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8812832 | 0.98 | SIGMAR1 (0.38) | CHRM5CHRM3SIGMAR1ITGB3ITGA2B | |
| SCHEMBL6187054 | 0.85 | CHRM5 (0.37) | CHRM5CHRM3SIGMAR1HTR2CTSHR | |
| SCHEMBL8968613 | 0.84 | ITGB3 (0.34) | CHRM5CHRM3SIGMAR1ITGB3ITGA2B | |
| SCHEMBL8024517 | 0.81 | SIGMAR1 (0.38) | CHRM5CHRM3SIGMAR1SMN1; SMN2 | |
| SCHEMBL9559920 | 0.76 | HTR2C (0.34) | CHRM5CHRM3SIGMAR1HTR2CHTR6 | |
| SCHEMBL27681986 | 0.76 | HTR6 (0.39) | HTR2CHTR6 | |
| SCHEMBL28752486 | 0.74 | HTR6 (0.38) | CHRM5CHRM3SIGMAR1SLC6A1SLC6A11 | |
| Hydrochloric Acid SCHEMBL27487446 | 0.74 | LTA4H (0.37) | CHRM5CHRM3SIGMAR1ITGB3ITGA2B | |
| SCHEMBL27682097 | 0.74 | HTR6 (0.40) | HTR2CHTR6 | |
| Hydrochloric Acid SCHEMBL1374273 | 0.74 | NPC1 (0.40) | ITGB3ITGA2BLMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6869957-B1 | Non-peptide tachykinin receptor antagonists | ELI LILLY AND COMPANY (US) | 2005-03-22 | — | — | US | disclosed |
| US-6727255-B1 | BRAIN, NERVOUS SYSTEM AND PSYCHOLOGICAL DISORDERS | ELI LILLY AND COMPANY | 2004-04-27 | — | — | US | disclosed |
| EP-0729468-B1 | NON-PEPTIDE TACHYKININ RECEPTOR ANTAGONISTS | LILLY CO ELI (US) | 2003-01-15 | — | — | EP | disclosed |
| US-6403577-B1 | Hexamethyleneiminyl tachykinin receptor antagonists | ELI LILLY AND COMPANY | 2002-06-11 | — | — | US | disclosed |
| US-6303610-B1 | ADMINISTERING TRYPTOPHAN DERIVATIVES AS NEUTROPHIL MEDIATED OXIDANT PRODUCTION FOR THERAPY OF NEUTROPHIL ASSOCIATED DISEASES AND DISORDERS | ELI LILLY AND COMPANY | 2001-10-16 | — | — | US | disclosed |
| EP-0912178-A4 | METHODS OF TREATING HYPERTENSION | LILLY CO ELI (US) | 2000-08-16 | — | — | EP | disclosed |
| EP-0994712-A1 | INHIBITORS OF NEUTROPHIL MEDIATED OXIDANT PRODUCTION | ELI LILLY AND COMPANY (US) | 2000-04-26 | — | — | EP | disclosed |
| US-6017930-A | Methods of treating or preventing interstitial cystitis | ELI LILLY AND COMPANY (US) | 2000-01-25 | — | — | US | disclosed |
| US-6001837-A | Methods of treating or preventing sleep apnea | ELI LILLY AND COMPANY (US) | 1999-12-14 | — | — | US | disclosed |
| EP-0912178-A1 | METHODS OF TREATING HYPERTENSION | ELI LILLY AND COMPANY (US) | 1999-05-06 | — | — | EP | disclosed |
| WO-1996024353-A1 | METHODS OF TREATING OR PREVENTING PSYCHIATRIC DISORDERS | ELI LILLY AND COMPANY (US) | 1996-08-15 | — | — | WO | disclosed |
| EP-0729468-A4 | NON-PEPTIDE TACHYKININ RECEPTOR ANTAGONISTS | LILLY CO ELI (US) | 1996-07-12 | — | — | EP | disclosed |
| US-5530009-A | TREATING ASTHMA | ELI LILLY AND COMPANY (US) | 1996-06-25 | — | — | US | disclosed |
| EP-0710479-A1 | Use of a serotonin agonist in combination with a tachykinin receptor antagonist for the manufacture of a medicament for the treatment or prevention of migraine | ELI LILLY AND COMPANY (US) | 1996-05-08 | — | — | EP | disclosed |
| WO-1996011000-A1 | METHODS OF TREATING MIGRAINE | ELI LILLY AND COMPANY (US) | 1996-04-18 | — | — | WO | disclosed |
| EP-0699674-A1 | 1-Aryl-2-acetylamidopentanone derivatives for use as tachykinin receptor antagonists | ELI LILLY AND COMPANY (US) | 1996-03-06 | — | — | EP | disclosed |
| WO-1996001819-A1 | HETEROCYCLIC TACHYKININ RECEPTOR ANTAGONISTS | ELI LILLY AND COMPANY (US) | 1996-01-25 | — | — | WO | disclosed |
| EP-0693489-A1 | Heterocyclic tachykinin receptor antagonists | ELI LILLY AND COMPANY (US) | 1996-01-24 | — | — | EP | disclosed |
| EP-0686629-A2 | Cyclohexyl tachykinine receptor antagonists | ELI LILLY AND COMPANY (US) | 1995-12-13 | — | — | EP | disclosed |
| WO-1995014017-A1 | NON-PEPTIDE TACHYKININ RECEPTOR ANTAGONISTS | ELI LILLY AND COMPANY (US) | 1995-05-26 | — | — | WO | disclosed |